Cargando…

Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies

BACKGROUND: So far, whether positive surgical margin(PSM) has adverse effects on the prognosis of patients is still controversial, so we designed this study to systematically evaluate the effect of PSM on the prognosis of patients with renal cell carcinoma (RCC) after partial nephrectomy (PN). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Renran, Gao, Liang, Wang, Jiawu, Jiang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399599/
https://www.ncbi.nlm.nih.gov/pubmed/36033492
http://dx.doi.org/10.3389/fonc.2022.945166
_version_ 1784772560431349760
author Bai, Renran
Gao, Liang
Wang, Jiawu
Jiang, Qing
author_facet Bai, Renran
Gao, Liang
Wang, Jiawu
Jiang, Qing
author_sort Bai, Renran
collection PubMed
description BACKGROUND: So far, whether positive surgical margin(PSM) has adverse effects on the prognosis of patients is still controversial, so we designed this study to systematically evaluate the effect of PSM on the prognosis of patients with renal cell carcinoma (RCC) after partial nephrectomy (PN). METHODS: On the basis of three electronic databases (PubMed, Embase and the Cochrane Library) up to May 2022, all case–control studies (CCSs) comparing the effects of PSM and negative surgical margin (NSM) after PN on the oncological results of RCC patients were included. Two evaluators independently conducted a systematic literature search and extracted the data we needed. The methodological quality of all studies was evaluated by the modified Newcastle–Ottawa scale. The odds ratio (OR) was used to describe the results for dichotomous variables, and the meta-analysis was conducted using Cochrane Review Manager 5.2 and Stata 14.2. RESULTS: A total of 39 studies involving 21461 patients were included in our meta-analysis. The pooled results showed that the rates of tumor recurrence (OR 3.93, 95% CI 2.95-5.24; p < 0.00001) and metastasis (OR 4.63, 95% CI 3.11-6.88; p < 0.00001) in the PSM group were significantly higher than those in the NSM group. However, there were no significant differences in the rates of all-cause death (OR 1.35, 95% CI 0.92-1.99; p = 0.13) or cancer-specific death (OR 0.99, 95% CI 0.51-1.94; p = 0.99) between the two groups. In addition, subgroup analyses were carried out according to different average follow-ups, which revealed similar results. CONCLUSION: Insignificant differences in survival between the PSM and NSM groups were observed, although significant differences in recurrence and metastasis in the PSM group were reported. Our study supported that close monitoring might be another effective choice for patients with PSM after PN. Considering the possible limitations, we recommended cautious interpretation of our results.
format Online
Article
Text
id pubmed-9399599
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93995992022-08-25 Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies Bai, Renran Gao, Liang Wang, Jiawu Jiang, Qing Front Oncol Oncology BACKGROUND: So far, whether positive surgical margin(PSM) has adverse effects on the prognosis of patients is still controversial, so we designed this study to systematically evaluate the effect of PSM on the prognosis of patients with renal cell carcinoma (RCC) after partial nephrectomy (PN). METHODS: On the basis of three electronic databases (PubMed, Embase and the Cochrane Library) up to May 2022, all case–control studies (CCSs) comparing the effects of PSM and negative surgical margin (NSM) after PN on the oncological results of RCC patients were included. Two evaluators independently conducted a systematic literature search and extracted the data we needed. The methodological quality of all studies was evaluated by the modified Newcastle–Ottawa scale. The odds ratio (OR) was used to describe the results for dichotomous variables, and the meta-analysis was conducted using Cochrane Review Manager 5.2 and Stata 14.2. RESULTS: A total of 39 studies involving 21461 patients were included in our meta-analysis. The pooled results showed that the rates of tumor recurrence (OR 3.93, 95% CI 2.95-5.24; p < 0.00001) and metastasis (OR 4.63, 95% CI 3.11-6.88; p < 0.00001) in the PSM group were significantly higher than those in the NSM group. However, there were no significant differences in the rates of all-cause death (OR 1.35, 95% CI 0.92-1.99; p = 0.13) or cancer-specific death (OR 0.99, 95% CI 0.51-1.94; p = 0.99) between the two groups. In addition, subgroup analyses were carried out according to different average follow-ups, which revealed similar results. CONCLUSION: Insignificant differences in survival between the PSM and NSM groups were observed, although significant differences in recurrence and metastasis in the PSM group were reported. Our study supported that close monitoring might be another effective choice for patients with PSM after PN. Considering the possible limitations, we recommended cautious interpretation of our results. Frontiers Media S.A. 2022-08-10 /pmc/articles/PMC9399599/ /pubmed/36033492 http://dx.doi.org/10.3389/fonc.2022.945166 Text en Copyright © 2022 Bai, Gao, Wang and Jiang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Bai, Renran
Gao, Liang
Wang, Jiawu
Jiang, Qing
Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies
title Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies
title_full Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies
title_fullStr Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies
title_full_unstemmed Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies
title_short Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies
title_sort positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: a meta-analysis based on 39 studies
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399599/
https://www.ncbi.nlm.nih.gov/pubmed/36033492
http://dx.doi.org/10.3389/fonc.2022.945166
work_keys_str_mv AT bairenran positivesurgicalmarginsmaynotaffectthesurvivalofpatientswithrenalcellcarcinomaafterpartialnephrectomyametaanalysisbasedon39studies
AT gaoliang positivesurgicalmarginsmaynotaffectthesurvivalofpatientswithrenalcellcarcinomaafterpartialnephrectomyametaanalysisbasedon39studies
AT wangjiawu positivesurgicalmarginsmaynotaffectthesurvivalofpatientswithrenalcellcarcinomaafterpartialnephrectomyametaanalysisbasedon39studies
AT jiangqing positivesurgicalmarginsmaynotaffectthesurvivalofpatientswithrenalcellcarcinomaafterpartialnephrectomyametaanalysisbasedon39studies